BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 23304450)

  • 1. Roles of Brain Angiotensin II in Cognitive Function and Dementia.
    Mogi M; Iwanami J; Horiuchi M
    Int J Hypertens; 2012; 2012():169649. PubMed ID: 23304450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of angiotensin II type 2 receptor on stroke, cognitive impairment and neurodegenerative diseases.
    Mogi M; Horiuchi M
    Geriatr Gerontol Int; 2013 Jan; 13(1):13-8. PubMed ID: 22726823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of angiotensin II receptor blockers on dementia.
    Mogi M; Horiuchi M
    Hypertens Res; 2009 Sep; 32(9):738-40. PubMed ID: 19727113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renin-Angiotensin System and Alzheimer's Disease Pathophysiology: From the Potential Interactions to Therapeutic Perspectives.
    Ribeiro VT; de Souza LC; Simões E Silva AC
    Protein Pept Lett; 2020; 27(6):484-511. PubMed ID: 31886744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of angiotensin II receptor subtype activation in cognitive function and ischaemic brain damage.
    Horiuchi M; Mogi M
    Br J Pharmacol; 2011 Jul; 163(6):1122-30. PubMed ID: 21175580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain angiotensin II and angiotensin IV receptors as potential Alzheimer's disease therapeutic targets.
    Royea J; Hamel E
    Geroscience; 2020 Oct; 42(5):1237-1256. PubMed ID: 32700176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Research Progress of Alzheimer's Disease Therapeutic Drugs: Based on Renin-Angiotensin System Axis.
    Li X; Xuan W; Chen D; Gao H; Wang G; Guo Q; Wang Y; Song H; Cai B
    J Alzheimers Dis; 2020; 78(4):1315-1338. PubMed ID: 33164932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Renin-Angiotensin System and the Neurodegenerative Diseases: A Brief Review.
    Almeida-Santos AF; Kangussu LM; Campagnole-Santos MJ
    Protein Pept Lett; 2017 Nov; 24(9):841-853. PubMed ID: 28828974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic approach for neuronal disease by regulating renin-angiotensin system.
    Ohshima K; Mogi M; Horiuchi M
    Curr Hypertens Rev; 2013 May; 9(2):99-107. PubMed ID: 23971691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of Renin-Angiotensin System May Slow Conversion from Mild Cognitive Impairment to Alzheimer's Disease.
    Wharton W; Goldstein FC; Zhao L; Steenland K; Levey AI; Hajjar I
    J Am Geriatr Soc; 2015 Sep; 63(9):1749-56. PubMed ID: 26389987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of the renin-angiotensin system and target organ protection.
    Iwanami J; Mogi M; Iwai M; Horiuchi M
    Hypertens Res; 2009 Apr; 32(4):229-37. PubMed ID: 19262496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain Renin-Angiotensin System at the Intersect of Physical and Cognitive Frailty.
    Cosarderelioglu C; Nidadavolu LS; George CJ; Oh ES; Bennett DA; Walston JD; Abadir PM
    Front Neurosci; 2020; 14():586314. PubMed ID: 33117127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective arms of the renin-angiotensin-system in neurological disease.
    Sumners C; Horiuchi M; Widdop RE; McCarthy C; Unger T; Steckelings UM
    Clin Exp Pharmacol Physiol; 2013 Aug; 40(8):580-8. PubMed ID: 23735163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Renin-Angiotensin System and the Cerebrovascular Diseases: Experimental and Clinical Evidence.
    Kangussu LM; Marzano LAS; Souza CF; Dantas CC; Miranda AS; Simões E Silva AC
    Protein Pept Lett; 2020; 27(6):463-475. PubMed ID: 31849284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic kidney disease accelerates cognitive impairment in a mouse model of Alzheimer's disease, through angiotensin II.
    Nakagawa T; Hasegawa Y; Uekawa K; Kim-Mitsuyama S
    Exp Gerontol; 2017 Jan; 87(Pt A):108-112. PubMed ID: 27916702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
    Weir MR
    Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of dementia by antihypertensive drugs: how AT1-receptor-blockers and dihydropyridines better prevent dementia in hypertensive patients than thiazides and ACE-inhibitors.
    Fournier A; Oprisiu-Fournier R; Serot JM; Godefroy O; Achard JM; Faure S; Mazouz H; Temmar M; Albu A; Bordet R; Hanon O; Gueyffier F; Wang J; Black S; Sato N
    Expert Rev Neurother; 2009 Sep; 9(9):1413-31. PubMed ID: 19769454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renin-angiotensin system as a potential therapeutic target in stroke and retinopathy: experimental and clinical evidence.
    Fouda AY; Artham S; El-Remessy AB; Fagan SC
    Clin Sci (Lond); 2016 Feb; 130(4):221-38. PubMed ID: 26769658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of brain renin angiotensin system in neurodegeneration: An update.
    Abiodun OA; Ola MS
    Saudi J Biol Sci; 2020 Mar; 27(3):905-912. PubMed ID: 32127770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beneficial Effect of Mas Receptor Deficiency on Vascular Cognitive Impairment in the Presence of Angiotensin II Type 2 Receptor.
    Higaki A; Mogi M; Iwanami J; Min LJ; Bai HY; Shan BS; Kukida M; Yamauchi T; Tsukuda K; Kan-No H; Ikeda S; Higaki J; Horiuchi M
    J Am Heart Assoc; 2018 Feb; 7(3):. PubMed ID: 29431106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.